Buy Triomune 40 Tablet Fro USA

triomune_40_tablets

About Triomune 40 Tablet

Triomune 40 Mg/150 Mg/200 Mg Tablet is a nucleoside analogue. It is used in combination with other medications to treat HIV infection. It functions by interfering with the growth of the HIV infection.

On using Triomune 40 you may experience side effects such as nausea, joint pain, difficulty sleeping, diarrhea, cough, dizziness, swelling of the mouth, headache, reduced appetite, weakness, vomiting, darkening of the urine, numbness, mental/ mood disorders, ear pain, itchiness, sore throat and chest pain. If your reactions persist or worsen over time seek the help of your health care provider right away.

What are the uses of Triomune 40?

Use of Triomune 40 Tablet is a medicine that is for the treatment of Hiv-1 infection, Hiv infection, Hepatitis b virus infection, Hiv, Suppression of immunity, Cancer and other conditions.

The complete list of uses and indications for Triomune 40 Tablet is as follows:

Hiv-1 infection

Hiv infection

Hepatitis b virus infection

Hiv

Suppression of immunity

Cancer

Infections

How to use Triomune Tablet

  How  Take Triomune 40 – this medicine take in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.

Triomune 40mg/150mg/200mg Tablet is to be taken empty stomach.

Take it preferably 1 hour before food.

How Triomune Tablet works

Triomune 150mg/40mg/200mg Tablet is a combination of three antiviral medicines: Lamivudine, Stavudine and Nevirapine. Triomune 40 work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.

Side Effect

In addition to its intended  side effect of Triomune 40 Mg/150 Mg/200 Mg Tablet may cause some unwanted effects too. In such cases, you must seek medical attention immediately. This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.

 Fatigue

 Headache

 Nausea

 Dizziness.

Expert advice for Triomune 40 Tablet

Consult your doctor if you have diabetes and are using insulin.

Patients receiving this therapy are always at a risk for infections and hence should report any such cases to the doctor.

Consult your doctor if you take any prescription medication; Inform your doctor if you take other medicine for treatment of HIV or hepatitis B infection, hairy cell leukemia [a type of blood cancer], or antibiotics for infection.

Triomune 40 may rarely cause a serious side effect like lactic acidosis with symptoms such as pain or weakness of muscle, numbness or feeling cold in arms or legs, stomach pain, nausea, vomiting, lack of breath, aberrant heart rate, dizziness, weak or tired feeling; hence, inform the doctor immediately if you experience any of these symptoms.

It is possible to pass on HIV when on Triomune 40 and hence it is important to take necessary precautions to prevent HIV from spreading.

Inform you doctor if you notice signs of change in the distribution of fat (lipodystrophy), erosion of bones (osteronecrosis), or inflammation of pancreas (pancreatitis).

If you are on therapy it is important to use effective non hormonal method of contraception or condom so that a pregnancy can be avoided.

Use with caution in pediatric patients with a history of pancreatitis or other significant risk factors for pancreatitis.

Triomune 40 Tablet – Precautions

Before using Triomune 40 Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug.

Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens.

Important counseling points are listed below.

Avoid drinking alcohol

Avoid pregnancy

Consult a doctor if you have liver or kidney disease or metabolic or lactic acidosis or peripheral neuropathy

Discontinue use if rapid increase in aminotransferase levels, progressive hepatomegaly, or metabolic or lactic acidosis of unknown origin

Do not start using nevirapine if you are allergic to it

Do not use if you are pregnant or breastfeeding

Do not use if you develop skin rash, blistering, mouth sores, swelling of the face, shortness of breath, muscle or joint pain or general feelings of illness

Have diabetes and renal impairment

Inflammation of the eye

Pregnancy

Signs of change in the distribution of fat, erosion of bones, or inflammation of pancreas

Stop using if you have skin rashes with fever

Symptoms like pain or weakness of muscle, numbness or feeling cold in arms or legs, stomach pain, nausea, vomiting, lack of breath, aberrant heart rate, dizziness, weak or tired feeling

Taken medications for AIDS or hepatitis B infection, hairy cell leukemia, or antibiotics for infection

Key highlights of Triomune 40mg 150 /Mg/200 Mg Tablet

 Are there any pregnancy warnings?

Triomune 40 tablet may be unsafe to use during pregnancy.

Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

 Are there any breast-feeding warnings?

Unknown. Human and animal studies are not available. Please consult your doctor.

 Is it safe to drive while on Triomune 40?

Patients may experience dizziness and/or somnolence, and they should avoid driving or operating machinery.

 Does this affect kidney function?

Caution to be advised in patients with moderate to severe impaired renal function.

Dose adjustment is required in patients with underlined renal diseases. Please consult your doctor.

For More information to visit our Site Medypharma.com

Have any Question or Comment?

Leave a Reply

Your email address will not be published. Required fields are marked *